跳至主要内容
临床试验/EUCTR2005-005048-19-IT
EUCTR2005-005048-19-IT进行中(未招募)不适用

A phase II randomised study to investigate the effects of Bevacizumab on cell proliferation and on pCR in patients with locally advanced operable breast cancer - ND

ISTITUTO EUROPEO DI ONCOLOGIA0 个研究点目标入组 120 人开始时间: 2006年1月31日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Patients with histologically proven primary breast cancer 2.0 cm, T2-T3 T4 a-d, N0-2, M0 Women aged 18 70 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients with overexpression HER2/neu 3 or amplification of HER2/neu gene evaluated by FISH, suitable for Herceptin containing regimens as primary therapy Patients with other non-malignant uncontrolled systemic diseases that would preclude trial entry in the opinion of the investigator. Specifically not eligible are patients with uncontrolled active infection, chronic infection such as active HBV or HCV INR greater than 1.50. Prior history of bleeding diathesis or coagulopathy including deep venous thrombosis or pulmonary embolism. Recent within last six months or current history of gastrointestinal bleeding.

研究者

相似试验

招募中
2 期
A randomised phase II study to evaluate the effectiveness of botulinum toxin to delay, and possibly prevent, progressive foot deformities in children with Charcot-Marie-Tooth (CMT) disease.Charcot-Marie-Tooth diseaseHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersNeurological - Other neurological disorders
ACTRN12605000115639The Children's Hospital at Westmead10
招募中
1 期
Effects of natural seaweed extract (GFS) on mobilisation of human bone marrow stem cells and immune system activatioormal volunteersNormal volunteersOther - Research that is not of generic health relevance and not applicable to specific health categories listed aboveInflammatory and Immune System - Normal development and function of the immune system
ACTRN12605000021673Tas100
招募中
2 期
Phase II randomized study to investigate the effectiveness of Hangeshashinto(TJ-14) against chemoradiation-induced oral and pharyngeal mucositishead and neck cancer
JPRN-UMIN000012948Department of Otolaryngolory-Head and Neck Surgery, National Defense Medical College of Japan90
尚未招募
2 期
A randomised phase 2 study of carboplatin with oral vinorelbine followed by maintenance therapy with oral vinorelbine or erlotinib in elderly patients with metastatic non-small cell lung cancer.on Small Cell Lung CancerNon Small Cell Lung CancerCancer - Lung - Non small cell
ACTRN12612000473864Southern Health100
进行中(未招募)
不适用
A phase 2 randomised trial to investigate the effects of recombinant human erythropoietin on infarct size in patients undergoing primary percutaneous coronary angiography for ST-segment elevation myocardial infarction. - Erythropoietin in acute MIAcute ST elevation myocardial infarctionMedDRA version: 9.1Level: LLTClassification code 10000891Term: Acute myocardial infarction
EUCTR2004-005259-32-GBImperial College Heathcare NHS Trust
A phase II randomised study to investigate the... | 临床试验